CRESTON M TATE DO NPI 1043280704

NPI Details

Creston M Tate, DO is a family medicine in York, PA with 32 years of experience. The provider is family Medicine is the medical specialty which is concerned with the total health care of the individual and the family. It is the specialty in breadth which integrates the biological, clinical, and behavioral sciences. The scope of family medicine is not limited by age, sex, organ system, or disease entity. Creston M Tate, DO NPI is 1043280704. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: AT STILL UNIVERSITY OF HEALTH SCIENCES, COLLEGE OF OSTEO MED, KIRKSVILLE
Graduation Year:1994

The provider's business location address is:

2149 S QUEEN ST
YORK, PA
ZIP 17403-845
Phone: (717) 356-4460
Fax: (717) 260-3326

The NPI 1043280704 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Injection, ketorolac tromethamine, per 15 mg (HCPCS:J1885)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Administration of vaccine (HCPCS:90471)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Diphtheria, tetanus, and acellular pertussis vaccine (7 years or older) (HCPCS:90715)
• Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme (HCPCS:J7620)
• Inhalation treatment for airway obstruction or sputum production (HCPCS:94640)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Urinalysis, manual test (HCPCS:81002)
• Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid 19), influenza a, influenza b, and respiratory syncytial virus, upper respiratory specimen, each reported as detected or not detected (HCPCS:0241U)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Influenza vaccine split virus, preservative free (HCPCS:90662)
• Injection, ceftriaxone sodium, per 250 mg (HCPCS:J0696)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• X-ray of chest, 2 views (HCPCS:71046)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
• X-ray of foot, minimum of 3 views (HCPCS:73630)
• X-ray of wrist, minimum of 3 views (HCPCS:73110)
• Removal of impacted ear wax by washing (HCPCS:69209)
• Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique (HCPCS:87651)
• X-ray of shoulder, minimum of 2 views (HCPCS:73030)
• X-ray of ankle, minimum of 3 views (HCPCS:73610)
• X-ray of ribs on side of body, minimum of 3 views (HCPCS:71101)
• X-ray of hip, 2-3 views (HCPCS:73502)

The enumeration date for this NPI number is 1/25/2006 and was last updated on 6/11/2025.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.